2024
Understanding Impact of CFTR Dysfunction on Airway Immune Cell Composition in Early Lung Disease Pathogenesis
Kockar Kizilirmak T, Yin H, Garrison A, Bruscia E, Egan M, Britto-Leon C. Understanding Impact of CFTR Dysfunction on Airway Immune Cell Composition in Early Lung Disease Pathogenesis. 2024, a6357-a6357. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6357.Peer-Reviewed Original ResearchCFTR Modulators Reprogram Sex-Specific Airway Neutrophil Signaling
Yin H, Kockar Kizilirmak T, Li N, Adams T, Sauler M, Gomez J, Britto-Leon C. CFTR Modulators Reprogram Sex-Specific Airway Neutrophil Signaling. 2024, a7454-a7454. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7454.Peer-Reviewed Original Research
2023
Hemoptysis in the Time of COVID
Kockar Kizilirmak T, Brumer E, Panacherry S, Egan M. Hemoptysis in the Time of COVID. 2023, a1928-a1928. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1928.Peer-Reviewed Original Research
2022
Ensuring Timely Pulmonary Follow Up After an Inpatient Asthma Hospitalization: A Quality Improvement Initiative
Brumer E, Cherian C, Godse S, Kockar Kizilirmak T, Grossman M, Chen L, Sheares B. Ensuring Timely Pulmonary Follow Up After an Inpatient Asthma Hospitalization: A Quality Improvement Initiative. 2022, a5722-a5722. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5722.Peer-Reviewed Original Research
2020
Low First Minute Apgar Scores Are Associated with Wheezing in Childhood
Kockar Kizilirmak T, Stern D, Guerra S, Wright A, Martinez F. Low First Minute Apgar Scores Are Associated with Wheezing in Childhood. 2020, a3697-a3697. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3697.Peer-Reviewed Original ResearchScreening for Latent Tuberculosis in Children With Immune-mediated Inflammatory Diseases Treated With Anti-tumor Necrosis Factor Therapy: Comparison of Tuberculin Skin and T-SPOT Tuberculosis Tests
Gİrİt S, Ayzit Atabek A, Şenol E, KoÇkar Kizilirmak T, Pekcan S, GÖktaŞ Ş, Öktem S, KasapÇopur Ö, ÇokuĞraŞ H. Screening for Latent Tuberculosis in Children With Immune-mediated Inflammatory Diseases Treated With Anti-tumor Necrosis Factor Therapy: Comparison of Tuberculin Skin and T-SPOT Tuberculosis Tests. Archives Of Rheumatology 2020, 35: 020-028. PMID: 32637916, PMCID: PMC7322294, DOI: 10.5606/archrheumatol.2020.7294.Peer-Reviewed Original ResearchTuberculin skin testLatent tuberculosis infectionValues of TSTSixth monthT-SPOTSkin testInflammatory diseasesTuberculosis testAnti-tumor necrosis factor therapyAnti-tumor necrosis factor treatmentNecrosis factor therapyAnti-TNF agentsAnti-TNF therapyProspective multicentric studyNecrosis factor treatmentFactor therapyLatent tuberculosisTuberculin skinTuberculosis infectionMulticentric studyLocal guidelinesTB testFactor treatmentPatientsMonths